Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the ac...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/69812bda3185416abd49d119a6d7fd35 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|